PATENT CLAIM ANALYSIS

Application Number: 16179722
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-06
Patent Classification: ["514", "007600"]

Abstract:
The present invention is directed to compositions and methods for the treatment of cancers, particularly cancers of epithelial origin. Therapy with a plurality of nutraceutical, non-chemotherapeutic and chemotherapeutic agents, that together target a plurality of cancer-supportive processes in a patient are disclosed. Among other things, the present invention encompasses the insight that redundant targeting of multiple such pathways provides effective treatment of various cancer, including late-stage cancers, metastasized cancers, and/or cancers that have failed treatment with traditional chemotherapy and/or other therapeutic modalities.

Claim (Index 94):
The method of  claim 90 , wherein the alpha-lipoic acid is administered at a dose within a range of 300-1200 mg/day.

Metadata:
- Claim Count in Document: 77.0
- Percentile: 98.0
- Lexical Diversity: 1.53333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14351766', '15518636', '15787398', '14284475', '15966848']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.726352950072896
- 35 USC 102 Novelty (BERT): 0.5550942694308162
- Combined Prediction Score: 0.709227082008688
- Mean Citation Score: 228.52262800000003
- Max Citation Score: 439.4445
- Similarity Product: 290.16741076469424

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test